<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://aktie.com/artikel/viking-therapeutics-nash-kandidat-vk2809-zeigt-anhaltende-wirkung-nach-52-wochen</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T12:00:30.774Z</news:publication_date>
      <news:title>Viking Therapeutics: NASH-Kandidat VK2809 zeigt anhaltende Wirkung nach 52 Wochen</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/us-einzelhandel-q2-2026-broadline-retailer-amazon</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:07:49.314Z</news:publication_date>
      <news:title>US-Einzelhandel Q2 2026: Warum Broadline-Retailer das Wachstum treiben – Amazon im Fokus</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/ray-dalio-erhoeht-sp-500-etf-position-spy-ivv-vergleich</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:06:17.151Z</news:publication_date>
      <news:title>Ray Dalio erhöht S&amp;P 500-ETF-Position um 6,2 Mrd. Dollar: Was der SPY vs. IVV-Vergleich für Anleger bedeutet</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/apple-aktie-neutrale-bewertung-analysten-warnung</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:04:38.161Z</news:publication_date>
      <news:title>Apple-Aktie mit neutraler Bewertung: Warum Analysten vor Einstieg zu aktuellen Kursen warnen</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/nvidia-beste-sp-500-aktie-20-jahre-4-tech-werte-5-jahres-performance</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:03:35.087Z</news:publication_date>
      <news:title>Nvidia beste S&amp;P 500-Aktie der letzten 20 Jahre: Welche 4 Tech-Werte die 5-Jahres-Performance toppen</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/microsoft-dow-jones-entwicklung-montag-august-2026</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:01:49.663Z</news:publication_date>
      <news:title>Microsoft im Fokus der Dow Jones-Entwicklung am Montag</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/sp-500-bull-market-august-2026-ai-superzyklus-treibt-us-aktien</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:01:46.937Z</news:publication_date>
      <news:title>S&amp;P 500 Bull Market setzt sich fort: Warum US-Aktien trotz hoher Bewertungen weiter steigen</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/alphabet-als-guenstigstes-mega-cap-tech-unternehmen-eingestuft-cloud-wachstum-ko-1787011309647</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:01:16.928Z</news:publication_date>
      <news:title>Alphabet als günstigstes Mega-Cap-Tech-Unternehmen eingestuft – Cloud-Wachstum kompensiert Investitionsdruck</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/beyond-meat-reverse-split-1-30-barclays-underweight</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:36.172Z</news:publication_date>
      <news:title>Beyond Meat vollzieht Reverse-Split im Verhältnis 1:30 – Barclays bleibt skeptisch</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/dividenden-etf-der-komplette-ratgeber-zu-passivem-einkommen-mit-ausschuettungen</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:29.866Z</news:publication_date>
      <news:title>Dividenden-ETF: Der komplette Ratgeber zu passivem Einkommen mit Ausschüttungen</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/nvidia-aktie-meistgehandelte-titel-us-markt</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T00:00:00.754Z</news:publication_date>
      <news:title>NVIDIA-Aktie unter meistgehandelten Titeln am US-Markt</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/viking-therapeutics-vktx-studiendaten-analysten-kurspotenzial</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T12:00:34.304Z</news:publication_date>
      <news:title>Viking Therapeutics mit positiven Studiendaten – Analysten sehen Kurspotenzial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/en/articles/viking-therapeutics-with-positive-study-data-analysts-see-upside-potential-cmsx6lxg</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T12:00:34.304Z</news:publication_date>
      <news:title>Viking Therapeutics with positive study data – analysts see upside potential</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/microsoft-analysten-kaufgelegenheit-ki-investitionen</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:02:35.517Z</news:publication_date>
      <news:title>Microsoft: Analysten sehen Kaufgelegenheit trotz hoher KI-Investitionen</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/en/articles/microsoft-analysts-see-buying-opportunity-despite-heavy-ai-investment-cmswh07n</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:02:35.517Z</news:publication_date>
      <news:title>Microsoft: Analysts See Buying Opportunity Despite Heavy AI Investment</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/berkshire-hathaway-alphabet-beteiligung-17-milliarden</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:01:57.233Z</news:publication_date>
      <news:title>Berkshire Hathaway stockt Alphabet-Beteiligung um 17 Milliarden Dollar auf</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/en/articles/berkshire-hathaway-boosts-alphabet-stake-by-17-billion-cmswgzc1</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:01:57.233Z</news:publication_date>
      <news:title>Berkshire Hathaway boosts Alphabet stake by $17 billion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/beyond-meat-reverse-split-aktie-verluste-august-2026</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:29.746Z</news:publication_date>
      <news:title>Beyond Meat vollzieht 1:30 Reverse-Split – Aktie steigt trotz anhaltender Verluste</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/en/articles/beyond-meat-executes-1-30-reverse-split-stock-rises-despite-ongoing-losses-cmswgxij</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:29.746Z</news:publication_date>
      <news:title>Beyond Meat Executes 1:30 Reverse Split – Stock Rises Despite Ongoing Losses</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/artikel/nvidia-recherche-material-unzureichend</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:02.896Z</news:publication_date>
      <news:title>Recherche-Material zu NVIDIA unzureichend für aktuellen Artikel</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://aktie.com/en/articles/nvidia-research-material-insufficient-for-current-article-cmswgwn0</loc>
    <news:news>
      <news:publication>
        <news:name>aktie.com</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T00:00:02.896Z</news:publication_date>
      <news:title>NVIDIA Research Material Insufficient for Current Article</news:title>
    </news:news>
  </url>
</urlset>
